Novel phospholipid-based drug formulation prevents degeneration of dopaminergic neurons from substantia nigra in a rat model of Parkinson’s disease.

Typeset version

 

TY  - CONF
  - Harris, D.M., Fisher, A., Harkin, A.J., Bolton,A.E., Sullivan, A.M., Nolan, Y.M.
  - Royal Irish Academy of Medicine
  - Novel phospholipid-based drug formulation prevents degeneration of dopaminergic neurons from substantia nigra in a rat model of Parkinson’s disease.
  - Dublin, Ireland
  - Poster Presentation
  - 2005
  - ()
  - 0
  - 05-JAN-05
  - 06-JAN-05
DA  - 2005/NaN
ER  - 
@unpublished{V380506,
   = {Harris,  D.M. and  Fisher,  A. and  Harkin,  A.J. and  Bolton, A.E. and  Sullivan,  A.M. and  Nolan,  Y.M. },
   = {Royal Irish Academy of Medicine},
   = {{Novel phospholipid-based drug formulation prevents degeneration of dopaminergic neurons from substantia nigra in a rat model of Parkinson’s disease.}},
   = {Dublin, Ireland},
   = {Poster Presentation},
   = {2005},
   = {()},
   = {0},
  month = {Jan},
   = {06-JAN-05},
  source = {IRIS}
}
AUTHORSHarris, D.M., Fisher, A., Harkin, A.J., Bolton,A.E., Sullivan, A.M., Nolan, Y.M.
TITLERoyal Irish Academy of Medicine
PUBLICATION_NAMENovel phospholipid-based drug formulation prevents degeneration of dopaminergic neurons from substantia nigra in a rat model of Parkinson’s disease.
LOCATIONDublin, Ireland
CONFERENCE_TYPEPoster Presentation
YEAR2005
TIMES_CITED()
PEER_REVIEW0
START_DATE05-JAN-05
END_DATE06-JAN-05
ABSTRACT
FUNDED_BY*